Trusted Press Release Distribution   Join | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Radiant Insights, Inc.
www.radiantinsights.com/
Michelle Thoras
sales@radiantinsights.com
1-415-349-0058
201 Spear St #1100, Suite #3036 San Francisco, CA 94105 United States


Bookmark and Share
Castration Resistant Prostate Cancer Treatment Market will grow at a CAGR of 9.01% till 2021
The report covers the present scenario and the growth prospects of the global castration resistant prostate cancer treatment market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.


Radiant Insights
BriefingWire.com, 7/17/2017 - Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

• Astellas Pharma

• Johnson & Johnson

• Sanofi

• Valeant

Other prominent vendors

• Active Biotech

• Advaxis

• ANI Pharmaceuticals

• Athenex

• Bavarian Nordic

• Bayer

• Bristol-Myers Squibb

• CureVac

• GlaxoSmithKline

• Innocrin Pharmaceutical

• Merck

• Myovant Sciences

• Northwest Biotherapeutics

• OncoGenex Pharmaceuticals

• Oncolytics Biotech

• Orion

• Sotio

• Madrigal Pharmaceuticals)

• Takeda Pharmaceutical

• Teva Pharmaceutical Industries

Browse the Full Research Report of Castration Resistant Prostate Cancer Treatment Market till 2021 at - www.radiantinsights.com/research/global-castration-resistant-prostate-cancer-treatment-market-2017-2021

Prostate cancer is also known as carcinoma of the prostate is cancer of the prostate gland that affects only the male population. It is a slow progressive disease. CRPC is an inveterate stage of prostate cancer, in which almost 90% of individuals develop metastases, specifically in the skeleton. The major therapies involved in the treatment of CRPC are hormonal therapy and chemotherapy.

The market is divided into the following segments based on geography:

• Americas

• APAC

• EMEA

Market driver

• Physician's preference toward hormonal therapy

• For a full, detailed list, view our report

Market challenge

• High cost of treatment

• For a full, detailed list, view our report

Market trend

• Increasing consolidation in cancer treatment market

• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2021 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

Request a Free Sample Copy of this Report @ www.radiantinsights.com/research/global-castration-resistant-prostate-cancer-treatment-market-2017-2021/request-sample

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2013 Proserve Technology, Inc.